Vasogen Inc.

Vasogen Inc. (Vasogen) is a biotechnology company engaged in the research and development of immune modulation therapies for the treatment of cardiovascular and neurodegenerative disorders. The lead product of the company is Celacade, a technology that targets the inflammation underlying chronic heart failure. The company is headquartered in Ontario, Canada.The operating loss of the company was CAD 16.59 million during the fiscal year 2008, as compared to an operating loss of CAD 30.03 million during 2007. The net loss of the company was CAD 16.07 million during the fiscal year 2008, as compared to a net loss of CAD 28.78 million during 2007.

Street: 
2505
City: 
Mississauga
Postcode: 
L5N 5S2
Federal State : 
Canada
WebSite: 
www.vasogen.com
Fax: 
1-905-5699231

Company Index Score

Current Index Score Historical Index Score
  • Vasogen Inc. currently scores 50 % in the index.
  • Vasogen Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Vasogen Inc. is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets